The Role of the Glycoprotein IIb Fibrinogen Receptor Subunit T2622G Gene Polymorphism (HPA-3) on Coronary Artery Disease and Acute Myocardial Infarction

References
1 Kroll H, Kiefel V, Santoso S. Clinical aspects and typing of platelet alloantigens. Vox Sang 1998; 74 (Suppl. 02) 345-54
2 Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-4
3 Böttinger C, Kastrati A, Koch W, Mehilli J, Seidl H, Schömig K, von Beckerath N, Schöming A. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 2000; 83: 559-62
4 Kroll H, Gardemann A, Fechter A, Haberbosch W, Santoso S. The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost 2000; 83: 392-6
5 Carl B, Kroll H, Bux J, Bein G, Santoso S. B-lymphoblastoid cell lines as source of reference DNA for genotyping of human platelet and neutrophil antigens. Transfusion 2000; 40: 62-8
6 Gardemann A, Humme J, Stricker J, Katz N, Philipp M, Tillmanns H, Hehrlein W, Rau M, Haberbosch W. Association of the platelet glycoprotein IIIa Pl^A1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost 1998; 80: 214-7.